TYRO3 as a potential therapeutic target in breast cancer.
Ekyalongo RC, Mukohara T, Funakoshi Y, Tomioka H, Kataoka Y, Shimono Y, Chayahara N, Toyoda M, Kiyota N, Minami H.
Ekyalongo RC, et al. Among authors: kataoka y.
Anticancer Res. 2014 Jul;34(7):3337-45.
Anticancer Res. 2014.
PMID: 24982338